Rocklatan Eye Drops and Eye Blood Flow in Glaucoma
Part of Eyes & vision clinical trials.
This study tests how the eye drop Rocklatan (a combination of latanoprost and netarsudil) affects blood flow in the back of the eye for people with early open-angle glaucoma. If you already use latanoprost but your eye pressure is still 17 or higher, this trial may explore if adding another medicine improves optic nerve health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have open-angle glaucoma in both eyes.
- Your visual field tests show glaucoma damage on your last two visits.
- You are currently using latanoprost eye drops in both eyes.
- Your eye pressure is 17 mmHg or higher while on latanoprost.
- Your optic nerve and nerve fiber layer measurements meet early glaucoma criteria.
- Your vision is 20/30 or better in both eyes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two eye drops—Rocklatan and latanoprost—for people with open-angle glaucoma who have already had a laser treatment (DSLT). It tests whether one drop works better than the other at lowering eye pressure after the laser.
This study compares two versions of latanoprost eye drops—one that contains a preservative and one that is preservative-free. It aims to see how each version affects the eye’s “goblet cells,” which help keep the eye surface healthy.
This study looks at how the optic nerve (the part of your eye that sends images to your brain) strains or bends in people who do not have glaucoma. It uses advanced eye imaging and home pressure checks to understand the nerve's health.
This study looks at whether a common class of glaucoma eye drops (called prostaglandin analogues) can protect the nerve cells in the back of the eye. It may help people with certain types of glaucoma who have been stable on one type of eye drop for at least 3 years.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.